| |
| |
|
| Insider
Information: |
Simpson Curran |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
123,327 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,893,069 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
123,327 |
|
|
| Total
Value |
$1,893,069 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Sr. VP, Operations |
2012-07-30 |
0 |
2007-03-10 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2024-01-02 |
123,327 |
2016-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
38,462 |
123,327 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2024-01-02 |
4 |
D |
$17.95 |
$145,754 |
D/D |
(8,120) |
84,865 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
67,945 |
92,985 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2023-01-03 |
4 |
D |
$22.68 |
$47,084 |
D/D |
(2,076) |
25,040 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,700 |
27,116 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2022-01-01 |
4 |
D |
$32.70 |
$43,556 |
D/D |
(1,332) |
16,416 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-14 |
4 |
AS |
$50.01 |
$580,716 |
D/D |
(11,612) |
17,748 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-14 |
4 |
OE |
$19.50 |
$395,498 |
D/D |
11,612 |
29,360 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-12 |
4 |
OE |
$19.50 |
$33,150 |
D/D |
1,700 |
19,448 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-12 |
4 |
AS |
$50.03 |
$85,051 |
D/D |
(1,700) |
17,748 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-07 |
4 |
AS |
$50.01 |
$259,302 |
D/D |
(5,185) |
17,748 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-07 |
4 |
OE |
$19.50 |
$101,108 |
D/D |
5,185 |
22,933 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,800 |
17,748 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-11 |
4 |
AS |
$50.13 |
$634,411 |
D/D |
(12,564) |
3,948 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-11 |
4 |
OE |
$22.00 |
$145,926 |
D/D |
6,633 |
16,512 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-10 |
4 |
AS |
$50.22 |
$2,231,224 |
D/D |
(44,429) |
9,879 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-10 |
4 |
OE |
$19.50 |
$858,098 |
D/D |
31,660 |
54,308 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-05 |
4 |
OE |
$13.09 |
$92,886 |
D/D |
5,137 |
28,285 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-05 |
4 |
AS |
$50.00 |
$281,850 |
D/D |
(5,637) |
22,648 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-12-09 |
4 |
S |
$43.40 |
$680,248 |
D/D |
(15,552) |
23,948 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-05-28 |
4 |
AS |
$50.00 |
$900,000 |
D/D |
(18,000) |
39,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-05-28 |
4 |
OE |
$22.00 |
$396,000 |
D/D |
18,000 |
57,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-02-25 |
4 |
AS |
$54.05 |
$286,465 |
D/D |
(5,300) |
39,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-02-25 |
4 |
OE |
$35.80 |
$189,740 |
D/D |
5,300 |
44,800 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-02-05 |
4 |
AS |
$50.08 |
$2,195,107 |
D/D |
(43,832) |
39,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
